Purchases and Sales Made in Q3 2024 in Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT) during Q3 2024. The information is specifically focused on institutions that hold shares of Nuvectis Pharma, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Oct 25, 2024
Q3 2024
|
Iridian Asset Management LLC
|
BUY
|
- |
55.4KNew |
$341K - $400K
|
55.4K
$260K
|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
50K+ 19.91% |
$308K - $362K
|
301K
$1.42M
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
26.5K+ 49.77% |
$163K - $192K
|
79.7K
$375K
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
26.5KNew |
$163K - $191K
|
26.5K
$124K
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
14.5K+ 181.19% |
$89K - $105K
|
22.4K
$105K
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
13.7K+ 105.34% |
$84.6K - $99.3K
|
26.8K
$126K
|
|
Nov 04, 2024
Q3 2024
|
Nations Financial Group Inc,
Cedar Rapids, IA |
BUY
|
- |
10KNew |
$61.6K - $72.3K
|
10K
$47K
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
8.95K+ 26.41% |
$55.1K - $64.7K
|
42.8K
$201K
|
|
Oct 15, 2024
Q3 2024
|
Baldwin Brothers LLC
|
BUY
|
- |
5.5K+ 3.26% |
$33.9K - $39.8K
|
174K
$818K
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
BUY
|
- |
4K+ 82.0% |
$24.7K - $28.9K
|
8.89K
$41.8K
|
|
Nov 05, 2024
Q3 2024
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
1.79K+ 3.7% |
$11K - $12.9K
|
50.1K
$236K
|
|
Oct 24, 2024
Q3 2024
|
Forbes J M & CO LLP
|
BUY
|
- |
982+ 2.07% |
$6.05K - $7.1K
|
48.4K
$227K
|
|
Nov 14, 2024
Q3 2024
|
Catalyst Funds Management Pty LTD
Sydney Nsw, C3 |
BUY
|
- |
900New |
$5.54K - $6.51K
|
900
$4.23K
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-2- 15.38% |
$12.3 - $14.5
|
11
$51.7
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-4- 0.52% |
$24.6 - $28.9
|
760
$3.57K
|
|
Oct 24, 2024
Q3 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-200- 94.34% |
$1.23K - $1.45K
|
12
$56.4
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-5.41K- 90.19% |
$33.3K - $39.1K
|
588
$2.76K
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-7.13K- 86.17% |
$43.9K - $51.5K
|
1.14K
$5.38K
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-7.85K- 76.98% |
$48.4K - $56.8K
|
2.35K
$11K
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-14.6K- 98.7% |
$89.7K - $105K
|
192
$902
|
|
Nov 13, 2024
Q3 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-34.6K- 69.39% |
$213K - $250K
|
15.3K
$71.7K
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-51K- 42.66% |
$314K - $368K
|
68.5K
$322K
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-58.7K- 78.79% |
$362K - $424K
|
15.8K
$74.3K
|